Voyager Therapeutics Management
Management criteria checks 2/4
Voyager Therapeutics' CEO is Al Sandrock, appointed in Mar 2022, has a tenure of 2.17 years. total yearly compensation is $3.17M, comprised of 19.7% salary and 80.3% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth €499.04K. The average tenure of the management team and the board of directors is 1.9 years and 4.9 years respectively.
Key information
Al Sandrock
Chief executive officer
US$3.2m
Total compensation
| CEO salary percentage | 19.7% |
| CEO tenure | 2.2yrs |
| CEO ownership | 0.1% |
| Management average tenure | 1.9yrs |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$3m | US$624k | US$132m |
| Sep 30 2023 | n/a | n/a | US$52m |
| Jun 30 2023 | n/a | n/a | US$96m |
| Mar 31 2023 | n/a | n/a | US$99m |
| Dec 31 2022 | US$7m | US$525k | -US$46m |
Compensation vs Market: Al's total compensation ($USD3.17M) is above average for companies of similar size in the German market ($USD993.35K).
Compensation vs Earnings: Al's compensation has been consistent with company performance over the past year.
CEO
Al Sandrock (65 yo)
2.2yrs
Tenure
US$3,172,433
Compensation
Dr. Alfred W. Sandrock Jr., also known as Al, M.D., Ph D., served as Director at Verge Analytics, Inc. since February 2022. He serves as Member of Scientific Advisory Board at Camp4 Therapeutics Corporatio...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.2yrs | US$3.17m | 0.12% $ 497.9k | |
| COO, Principal Financial & Accounting Officer and Acting Chief Business Officer | less than a year | US$1.38m | 0.22% $ 927.1k | |
| Chief Legal Officer | less than a year | US$1.91m | no data | |
| Founder | no data | no data | no data | |
| Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Chief Scientific Officer | 1.7yrs | no data | 0.16% $ 694.3k | |
| Chief Human Resources Officer | 3.7yrs | no data | no data | |
| Senior Vice President of Translational Medicine & Clinical Development | 3.8yrs | no data | no data | |
| Senior Financial Advisor | less than a year | US$1.79m | 0.068% $ 293.2k | |
| Chief Corporate Affairs Officer & Chief of Staff to the CEO | 2.3yrs | no data | no data |
1.9yrs
Average Tenure
53yo
Average Age
Experienced Management: VT6's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.3yrs | US$3.17m | 0.12% $ 497.9k | |
| Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Consultant & Member of Scientific Advisory Board | 4.9yrs | US$1.81m | no data | |
| Independent Director | 10.3yrs | US$263.78k | 0.14% $ 606.9k | |
| Independent Director | 7.3yrs | US$248.78k | 0.040% $ 172.6k | |
| Independent Director | 8.7yrs | US$255.78k | 0% $ 0 | |
| Independent Chairman of the Board | 8.8yrs | US$281.28k | 0.058% $ 248.1k | |
| Independent Director | 1.8yrs | US$250.78k | 0% $ 0 | |
| Independent Director | 1.3yrs | US$432.23k | 0% $ 0 | |
| Independent Director | 3.7yrs | US$255.28k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data |
4.9yrs
Average Tenure
65yo
Average Age
Experienced Board: VT6's board of directors are considered experienced (4.9 years average tenure).